Discover the adverse effects of Nuplazid, a medication for Parkinson’s disease psychosis, amidst the ongoing Nuplazid lawsuit. Learn about its benefits, risks, and the lawsuits surrounding it. Stay informed with updates on Nuplazid lawsuit developments.
Drug Purpose: It is approved for use in treating Parkinson’s patients’ hallucinations and delusions. It’s the only drug of its kind specifically for this purpose.
Controversy: Despite its approval, there have been concerns about its safety and efficacy. Some patients and families have reported adverse effects, including worsening symptoms or even death, leading to legal action.
Legal Claims: Lawsuits filed against the manufacturer claim that it failed to properly alert people to the possible hazards connected to Nuplazid. The plaintiffs argue that, prior to taking the medication, they were not given enough information regarding its risks.
FDA Review: The Food and Drug Administration (FDA) of the United States has examined a “black box” label that indicates concerns for older patients who have psychosis associated with dementia. However, in 2023, Nuplazid’s use was extended to include all cases of psychosis associated with Parkinson’s disease.
Side Effects: Like any medication, Nuplazid also has side effects. Common side effects include nausea, swelling, and confusion. However, some patients have experienced more severe reactions, which has sparked concern.
Ongoing Research: Scientists are continually studying Nuplazid to better understand its effects and determine any long-term risks. This research is crucial for both patients and healthcare providers to make informed decisions.
Seek Medical Experts: It’s vital to keep lines of communication open with your physician if you’re taking Nuplazid or are thinking about it. Discuss any concerns or potential side effects, and work together to find the best treatment approach.
Contact an attorney: If you believe you or a loved one have been harmed by Nuplazid, it’s advisable to seek legal counsel. An attorney can help assess your case and determine if you’re eligible for compensation.
Future of Nuplazid: Despite the controversies, Nuplazid remains on the market, and ongoing research may lead to clearer guidance on its use. However, it’s essential for both patients and healthcare professionals to stay informed and vigilant about its potential risks.
In summary, the Nuplazid lawsuits highlight the importance of transparency, communication, and ongoing research in medication safety. Patients should be aware of potential risks, advocate for their health, and seek legal assistance if they believe they’ve been harmed.
Follow our blog for updates to stay safe and informed about Nuplazid and related legal developments.
Discover how Band-Aids help protect our wounds, how Mamavation found out about the PFAS contamination in popular adhesive bandage brands, and how to join a Band-Aid lawsuit against these PFAS-contaminated Band-Aids. Lets discuss what you need?
Band-Aids have been our go-to for healing small cuts and scrapes since childhood. We trusted them to protect our wounds and help them heal faster. But recent lawsuits have raised concerns about the safety of some Band-Aids. Let’s see more about the controversy and the Band-Aid lawsuits.
Sharnay Moultrie filed a lawsuit against Johnson & Johnson and Kenvue Inc., alleging that their Band-Aid products contain harmful chemicals called PFAS (per-and polyfluoroalkyl substances). These chemicals, also known as “Forever chemicals,” can cause serious health problems like cancer and liver damage.
A study by Mamavation found that many Band-Aids from different brands contained high levels of PFAS. Even bandages marketed for darker skin tones showed traces of these harmful chemicals. This is worrying because Band-Aids go directly onto open wounds, making it easy for PFAS to enter our bodies. PFAS can penetrate and accumulate in our bodies and environments over time. According to the data, 97% of Americans people have PFAS in their blood.
Among the brands, BAND-AID OURTONE Flexible Fabric BR65 Bandages are the worst with a peak adhesive part weight of 374 PPM and an absorbent pad weight of 260 PPM.
The lawsuit claims that the PFAS levels in these Band-Aids exceed safety limits set by the EPA. Sharnay Moultrie argues that if she had known about the presence of PFAS, she wouldn’t have bought the products or would have paid less for them. She seeks compensation for financial losses due to the premium charge on these supposedly safe Band-Aids.
Johnson & Johnson and Kenvue Inc. are accused of deceptive marketing. They claim their Band-Aids are recommended by doctors and safe for the skin, but they don’t disclose the presence of PFAS on their packaging. This misleads customers into believing the products are toxin-free.
If you want to join the lawsuit or similar class action lawsuits related to harmful chemicals in bandages, you can contact a lawyer specializing in consumer protection. It’s important to act promptly if you believe you’ve been affected by these chemicals.
Overall, the discovery of PFAS in Band-Aids highlights the need for manufacturers to prioritize safer alternatives. As consumers, we should advocate for the use of PFAS-free products to ensure our safety.
Jaundice in babies makes their skin yellow due to too much bilirubin. It’s common, but severe cases can cause brain damage called kernicterus. Kernicterus is serious but can be prevented with proper medical help.
In newborns, jaundice, characterized by yellowing of the skin, can sometimes progress rapidly to kernicterus, a severe brain injury. To prevent such outcomes, doctors must be careful when identifying and managing jaundice. This involves assessing risk factors before birth, closely monitoring newborns for jaundice signs immediately after delivery and during the first few days of life, and performing blood tests to measure bilirubin levels.
While newborns are typically affected, adults may also be affected in rare instances.
Kernicterus is brain damage caused by severe jaundice, a yellowing of the eyes often seen in newborns. Due to the fact that jaundice is typically treated before it becomes harmful, kernicterus only affects approximately 1 in 44,000 babies in wealthy countries.
Kernicterus means there are high levels of bilirubin in the blood and toxic levels in the brain. It affects the brain. The symptoms are
- Lack of energy
- Involuntary muscle movements
- Hearing loss
- Cerebral palsy
- Coma
Prompt intervention is crucial if jaundice symptoms or complications arise, with treatments such as phototherapy or blood transfusions often employed to lower bilirubin levels and prevent kernicterus.
Identifying jaundice in newborns is crucial. However, in some hospital nurseries, this step is overlooked, increasing the risk of complications like kernicterus. Nurses and doctors must be diligent in visually assessing jaundice severity and promptly initiating treatment when necessary. Failure to act swiftly can result in lifelong neurological issues for the child.
Common mistakes made by physicians include delays in treating jaundice or interrupting phototherapy, which can worsen outcomes. Additionally, misinterpreting bilirubin test results based on the infant’s age can lead to inadequate intervention. It’s essential for medical professionals to be vigilant, ensuring timely and appropriate management to prevent serious complications associated with neonatal jaundice.
If a baby clearly has jaundice, doctors need to follow the latest guidelines. If they don’t, some babies might miss out on needed treatments or tests. If your child or a loved one’s child has jaundice complications, it’s important to find out if mistakes caused them harm.
If your baby got kernicterus because of medical malpractice, you might be able to sue for compensation. To file a kernicterus lawsuit, find a lawyer experienced in medical malpractice or birth injury cases. Parents should be aware of the risk of kernicterus and brain damage.